Are you a new member? Sign up now
Login area
| Sign up
close
CEFUROXIME – PANPHARMAPOUDRE POUR SOLUTION INJ. IM/IV - 750mg - 25
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J01DC02 | G | Cefuroxime (sodium) - 750mg | 2272 | 0236861/99 | CEFUROXIME – PANPHARMAPOUDRE POUR SOLUTION INJ. IM/IV | 750mg | 25 | Injectable dry powder | IV/IM | Minapharm Halabi | Panpharma | France | 3,922,676 L.L | 23.08 | B | Panpharma | France | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J01DC02 | G | Cefuroxime sodium - 750mg | 9632 | 79316/1 | AXETINE | 750mg | 10 | Injectable powder for solution | Infusion/IV/IM | New Allpharma | Medochemie Ltd | Cyprus | 1,193,332 L.L | 23.08 | A2 | Medochemie Ltd | Cyprus | 2/5/2024 | 0 |
| J01DC02 | G | Cefuroxime (sodium) - 750mg | 1842 | 208669/03 | CEFUMAX | 750mg | 1 | Injectable dry powder | IV/IM | C. Catafago & Co | Pharco Pharmaceuticals | Egypt | 159,917 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| J01DC02 | G | Cefuroxime (sodium) - 750mg | 5966 | 168034/10 | CEFUROXIME – PANPHARMAPOUDRE POUR SOLUTION INJ. IM/IV | 750mg | 10 | Injectable powder for solution | IV/IM | Minapharm Halabi | Panpharma | France | 1,651,582 L.L | 23.08 | B | Panpharma | France | 2/5/2024 | 0 |
| J01DC02 | G | Cefuroxime (sodium) - 750mg | 1394 | 208593/03 | CEFUZIME | 750mg | 1 | Injectable dry powder | IV/IM | Pharmanet Drugstore S.A.R.L. | Julphar | United Arab Emirates | 147,823 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| J01DC02 | G | Cefuroxime - 750mg | 9240 | 40816/1 | MAXIL 750 | 750mg | 1 | Injectable dry powder | Infusion/IV/IM | Abela Frères S.A.L. | Hikma Farmaceutica | Portugal | 159,917 L.L | 23.08 | A1 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
| J01DC02 | G | Cefuroxime (sodium) - 750mg | 2334 | 974030/02 | ZILISTEN | 750mg | 1 | Injectable dry powder | IV/IM | Macromed S.A.R.L. | Demo SA | Greece | 155,886 L.L | 23.08 | A1 | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024